Pharmacy

Home Pharmacy

CDC Endorses Booster Shots for Millions of Americans

Recommendations came just one day after the FDA authorized boosters for several vulnerable groups at least six months after the second dose

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans

Exactly who qualifies as high risk because of health or work reasons is not yet clear

Many Oral Anticancer Drugs Require Prior Authorization

Median time to drug receipt was seven days; prior authorization was associated with delayed time to drug receipt

Survival Up With Tebentafusp in Metastatic Uveal Melanoma

Overall survival longer with tebentafusp for HLA*02:01-positive patients with previously untreated metastatic uveal melanoma

RAI Therapy for Hyperthyroidism Not Tied to Overall Cancer Risk

However, linear radiation dose-response association between radioactive iodine and solid cancer mortality seen in two studies

HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045

However, reductions in oropharynx cancer incidence should be seen among young and middle-aged adults

Metformin May Prolong Gestation in Women With Preterm Preeclampsia

No difference seen in circulating concentrations of soluble fms-like tyrosine kinase-1, placental growth factor, soluble endoglin

First Biosimilar Approved for Macular Degeneration, Other Eye Conditions

Biosimilar to Lucentis approved to treat neovascular age-related macular degeneration, macular edema, myopic choroidal neovascularization

Oxcarbazepine Tied to Nontrauma Fracture in Children Aged 4 to 13 With Epilepsy

Initiating oxcarbazepine, but not levetiracetam, linked to increased incidence rate ratio for nontrauma fracture